Sep 13 |
Candel Therapeutics, Inc. (NASDAQ:CADL) most popular amongst individual investors who own 48%, insiders hold 30%
|
Sep 4 |
Milestone Pharmaceuticals Appoints Industry Veteran Joseph Papa to its Board of Directors
|
Sep 3 |
Candel Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
|
Aug 13 |
Candel Therapeutics GAAP EPS of -$0.74
|
Aug 13 |
Candel Therapeutics Reports Second Quarter 2024 Financial ResultsĀ and Recent Corporate Highlights
|
Jul 1 |
Candel Therapeutics: Innovative Cancer Therapies, But Short Cash Runway
|
Jun 18 |
Candel Therapeutics to Participate in the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference
|
Jun 14 |
Candel Therapeutics' (NASDAQ:CADL) enLIGHTEN Discovery Platform Aims To Tackle Complexities Of Tumor Microenvironments
|
Jun 14 |
7 A-Rated Biotech Stocks Worth Betting on in June
|
Jun 11 |
Candel Therapeutics to join Russell 3000 Index
|